ARTICLE | Management Tracks
Agresta joining OnKure as CMO
Plus: Viridian hires Tousignant and an update from Ligand
February 17, 2024 12:56 AM UTC
Cancer company OnKure Inc. hired Samuel Agresta as CMO. Agresta was CMO at Foghorn Therapeutics Inc. (NASDAQ:FHTX).
Viridian Therapeutics Inc. (NASDAQ:VRDN) hired Jennifer Tousignant, former SVP of legal at Sana Biotechnology Inc. (NASDAQ:SANA), as chief legal officer. Viridian is developing IGF1R-targeting antibody VRDN-001 to treat thyroid eye disease. ...